Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 776 - 800 of 1458 in total
An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
Experimental
Clobutinol is a cough suppressant that is withdrawn from the US and EU markets. Clobutinol may prolong the QT interval. In 2007, Clobutinol was determined to cause cardiac arrhythmia in some patients.
Withdrawn
Beclamide (N-benzyl-B-chloropropionamide) is a no longer used drug that possesses anticonvulsant and sedative activity. It was studied in the 1950s for generalised tonic-clonic seizures but was not effective for absence seizures.
Experimental
Radafaxine has been used in trials studying the treatment of Depressive Disorder, Major.
Investigational
Basimglurant has been used in trials studying the diagnostic and treatment of Depression, Fragile X Syndrome, and Major Depressive Disorder.
Investigational
Experimental
Experimental
Developed by the German pharmaceutical company, Merckle GmbH, together with EuroAlliance partners Alfa Wassermann and Lacer, licofelone (ML3000) is a dual COX/LOX inhibitor and the first member of this new class of analgesic and anti-inflammatory drugs. It is currently under evaluation as a treatment for osteoarthritis (OA), the most common...
Investigational
Experimental
GSI-136 has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer).
Investigational
Experimental
Displaying drugs 776 - 800 of 1458 in total